Publication of List of Manufacturers Revoked Licence for the Manufacture of Therapeutic Goods

Overview

The Therapeutic Goods Act 1989 was enacted to regulate the supply of therapeutic goods in Australia, ensuring their quality, safety, and efficacy. The Act addresses the need for a robust framework governing the manufacture, supply, and advertising of therapeutic goods, aiming to protect public health by establishing standards and controls over these products. The Therapeutic Goods Administration, as part of the Department of Health, administers this Act, which includes provisions for licensing manufacturers and regulating their operations to ensure compliance with health and safety standards. The policy objective of the Act is to safeguard the health of the Australian public by ensuring that therapeutic goods available in the market meet required safety and quality standards.

Scope and Application

The Therapeutic Goods Act 1989 applies to entities that manufacture, import, supply, or otherwise deal with therapeutic goods within Australia. This encompasses a wide range of entities including medical device manufacturers, pharmaceutical companies, and other healthcare-related businesses. The Act regulates the quality, safety, and efficacy of therapeutic goods to ensure they are safe for consumers. It extends across the Commonwealth and applies nationally, ensuring consistent regulatory standards are maintained throughout Australia. The Act does not specify exclusions or exemptions, but its application may be further defined through subordinate legislation or regulations, which can provide detailed guidance on certain aspects of the therapeutic goods market, such as specific types of products or manufacturing processes. The revocation of a Licence to Manufacture Therapeutic Goods, as detailed in the gazette, applies to the named entities at their specific locations, indicating that the Act's provisions allow for the Secretary to revoke licences at the request of the manufacturer, reflecting the Act's flexible approach to managing the therapeutic goods market.

Key Provisions

The Therapeutic Goods Act 1989 (the Act) provides the framework for the regulation of therapeutic goods in Australia. Section 41(1)(d) of the Act allows the Secretary to revoke a licence to manufacture therapeutic goods. In this case, the Secretary has revoked several licences at the request of the manufacturers (s41(1)(d)). The affected licences include those held by Peter MacCallum Cancer Institute, Scentral Pacific Pty Ltd, Department of Health QLD trading as Forensic and Scientific Services, Finishing Services Pty Ltd, Australian Red Cross Lifeblood, National Institute of Complementary Medicine, Sydney Cord Blood Bank, and Jurlique International Pty Ltd. These revocations are significant because they indicate that these entities are no longer authorised to manufacture therapeutic goods in Australia. The revocation of these licences imposes obligations on the affected entities to cease any manufacturing activities related to the therapeutic goods covered by their licences. This includes stopping the production, packaging, labelling, and distribution of any therapeutic goods that were previously manufactured under these licences. The revocation also means that these entities are no longer permitted to use the licences for any manufacturing purposes and must comply with any additional instructions or conditions set by the Secretary. Failure to comply with these obligations can lead to further action by the Therapeutic Goods Administration. Breaching the requirements of the Act can result in various civil and criminal consequences. Under section 42(1) of the Act, a person who contravenes a provision of the Act can be subject to a civil penalty. The maximum penalty for individuals is $22,200, and for bodies corporate, the penalty can be up to $222,000. Additionally, section 42(2) provides that an offence under the Act can be prosecuted by indictment, meaning that the accused can be tried in a higher court. Furthermore, the Act allows for the imposition of other penalties as determined by the court, which may include fines, imprisonment, or both, depending on the severity of the breach. The precise penalties depend on the specific provisions of the Act that have been contravened and the circumstances of the breach.